According to our (Global Info Research) latest study, the global Sterile Hypodermic Single Use Syringe market size was valued at US$ 8541 million in 2025 and is forecast to a readjusted size of US$ 12020 million by 2032 with a CAGR of 5.1% during review period.
A sterile hypodermic single use syringe is a fundamental medical device widely used in healthcare, scientific research, veterinary medicine, and public health. It is primarily designed to deliver liquid medications into the subcutaneous, intramuscular, or intravenous tissues of humans or animals and can also be used to draw bodily fluids or blood samples. The product consists of a barrel, plunger, rubber stopper, and needle, and is typically made from non-toxic, sterile materials such as medical-grade polypropylene (PP) and stainless steel, ensuring good biocompatibility and operational safety. Each syringe undergoes strict sterilization before leaving the factory, is intended for single use, and must be properly disposed of after use to prevent cross-contamination.
Sterile hypodermic single use syringes are widely applied in vaccine administration (e.g., influenza vaccine, COVID-19 vaccine), chronic disease management (e.g., insulin injection for diabetes patients), antibiotic and hormone therapies, preoperative and postoperative anesthetic administration, as well as in the extraction and testing of bodily fluids. In laboratories, they are also commonly used for sample extraction and precise liquid dispensing. In veterinary medicine, these syringes serve as essential tools for livestock and pet vaccination and treatment.
In 2024, the global sales of sterile hypodermic single use syringes exceeded 71 billion units, with an average ex-factory price of approximately $110 per thousand units.
The North American market for sterile hypodermic single use syringes is mature, driven by advanced healthcare infrastructure, high rates of chronic disease management, and widespread vaccination programs. The U.S. and Canada maintain strict regulatory standards for product quality and safety, which has encouraged innovation in needle safety mechanisms and eco-friendly materials. Additionally, government-led immunization campaigns and the prevalence of insulin-dependent diabetes patients contribute to steady demand.
Europe’s sterile hypodermic single use syringe market is supported by robust public healthcare systems and strong emphasis on patient safety. Countries such as Germany, France, and the U.K. are early adopters of safety-engineered syringes to reduce needlestick injuries. The region’s market growth is also influenced by ongoing vaccination drives, aging populations, and EU directives promoting the use of recyclable and environmentally sustainable materials in medical devices.
The Asia-Pacific region is the fastest-growing market, with China, India, and Japan as key drivers. Rapid urbanization, expanding healthcare access, and large-scale government immunization programs, including COVID-19 vaccination efforts, have significantly boosted demand. In addition, the rise of domestic syringe manufacturing in China and India has improved product affordability and availability, while Japan focuses on high-quality, precision-engineered products.
In Latin America, countries such as Brazil and Mexico are experiencing rising demand due to public vaccination programs and improved healthcare accessibility. However, the market faces challenges from budget constraints in public hospitals and dependence on imports in some regions. Local manufacturing initiatives are emerging to reduce reliance on foreign suppliers.
The Middle East & Africa market is growing steadily, supported by expanding healthcare infrastructure and increased government spending on vaccination campaigns. Gulf countries, led by the UAE and Saudi Arabia, focus on premium medical devices, while African nations are gradually improving syringe supply chains through public-private partnerships and donor-funded health programs.
This report is a detailed and comprehensive analysis for global Sterile Hypodermic Single Use Syringe market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Sterile Hypodermic Single Use Syringe market size and forecasts, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/K Units), 2021-2032
Global Sterile Hypodermic Single Use Syringe market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/K Units), 2021-2032
Global Sterile Hypodermic Single Use Syringe market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/K Units), 2021-2032
Global Sterile Hypodermic Single Use Syringe market shares of main players, shipments in revenue ($ Million), sales quantity (M Units), and ASP (US$/K Units), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Sterile Hypodermic Single Use Syringe
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Sterile Hypodermic Single Use Syringe market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include BD, Terumo, Cardinal Health, MTD Group, Nipro Corp, Merit Medical, B. Braun, ICU Medical, Hindustan Syringes & Medical Devices, Feel Tech Bio, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Sterile Hypodermic Single Use Syringe market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Conventional Syringes
Safety Syringes
Market segment by Application
Hospitals and Clinics
Diagnostic Laboratories
Others
Major players covered
BD
Terumo
Cardinal Health
MTD Group
Nipro Corp
Merit Medical
B. Braun
ICU Medical
Hindustan Syringes & Medical Devices
Feel Tech Bio
WEGO
Zhejiang Kindly Medical
Jiangxi Sansin
Jiangsu Caina
Anhui Hongyu Wuzhou
Hangzhou Promisemed
Berpu Medical
Shandong Qiaopai
Jiangsu Zhengkang
Henan Shuguang Jianshi
Jiangsu Jichun
Shengguang Group
Jiangxi Hongda
Shifeng Medical
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Sterile Hypodermic Single Use Syringe product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Sterile Hypodermic Single Use Syringe, with price, sales quantity, revenue, and global market share of Sterile Hypodermic Single Use Syringe from 2021 to 2026.
Chapter 3, the Sterile Hypodermic Single Use Syringe competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Sterile Hypodermic Single Use Syringe breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Sterile Hypodermic Single Use Syringe market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Sterile Hypodermic Single Use Syringe.
Chapter 14 and 15, to describe Sterile Hypodermic Single Use Syringe sales channel, distributors, customers, research findings and conclusion.
Summary:
Get latest Market Research Reports on Sterile Hypodermic Single Use Syringe. Industry analysis & Market Report on Sterile Hypodermic Single Use Syringe is a syndicated market report, published as Global Sterile Hypodermic Single Use Syringe Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Sterile Hypodermic Single Use Syringe market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.